Surf4 deficiency reduces intestinal lipid absorption and secretion and decreases metabolism in mice

Background Postprandial dyslipidemia is a causative risk factor for cardiovascular disease. The majority of absorbed dietary lipids are packaged into chylomicron and then delivered to circulation. Previous studies showed that Surfeit4 (Surf4) mediates very low-density lipoprotein secretion from hepatocytes. Silencing hepatic Surf4 markedly reduces the development of atherosclerosis in different mouse models of atherosclerosis without causing hepatic steatosis. However, the role of Surf4 in chylomicron secretion is unknown. Methods We developed inducible intestinal-specific Surf4 knockdown mice (Surf4IKO) using Vil1Cre-ERT2 and Surf4flox mice. Metabolic cages were used to monitor mouse metabolism. Enzymatic kits were employed to measure serum and tissue lipid levels. The expression of target genes was detected by qRT-PCR and Western Blot. Transmission electron microscopy and radiolabeled oleic acid were used to assess the structure of enterocytes and intestinal lipid absorption and secretion, respectively. Proteomics was performed to determine changes in protein expression in serum and jejunum. Results Surf4IKO mice, especially male Surf4IKO mice, displayed significant body weight loss, increased mortality, and reduced metabolism. Surf4IKO mice exhibited lipid accumulation in enterocytes and impaired fat absorption and secretion. Lipid droplets and small lipid vacuoles were accumulated in the cytosol and the endoplasmic reticulum lumen of the enterocytes of Surf4IKO mice, respectively. Surf4 colocalized with apoB and co-immunoprecipitated with apoB48 in differentiated Caco-2 cells. Intestinal Surf4 deficiency also significantly reduced serum triglyceride, cholesterol and free fatty acid levels in mice. Proteomics data revealed that diverse pathways were altered in Surf4IKO mice. In addition, Surf4IKO mice had mild liver damage, decreased liver size and weight, and reduced hepatic triglyceride levels. Conclusion Our findings demonstrate that intestinal Surf4 plays an essential role in lipid absorption and chylomicron secretion and suggest that the therapeutic use of Surf4 inhibition requires highly cell/tissue-specific targeting. Highlights Intestinal Surf4 deficiency reduces chylomicron secretion. Lack of intestinal Surf4 reduces absorption of dietary lipids. Silencing intestinal Surf4 reduces serum lipid levels. Intestinal Surf4 deficiency leads to lipid accumulation in intestinal villi. Intestinal Surf4 is essential for dietary lipid absorption and secretion.

[1]  H. Tilg,et al.  Gut-liver axis: Pathophysiological concepts and clinical implications. , 2022, Cell metabolism.

[2]  Brian T. Emmer,et al.  Hepatic inactivation of murine Surf4 results in marked reduction in plasma cholesterol , 2022, bioRxiv.

[3]  S. Qin,et al.  The role of hepatic Surf4 in lipoprotein metabolism and the development of atherosclerosis in apoE-/- mice. , 2022, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[4]  Kota Saito,et al.  Cargo receptor Surf4 regulates endoplasmic reticulum export of proinsulin in pancreatic β-cells , 2022, Communications Biology.

[5]  Yong Liu,et al.  Ablation of Plasma Prekallikrein Decreases Low-Density Lipoprotein Cholesterol by Stabilizing Low-Density Lipoprotein Receptor and Protects Against Atherosclerosis , 2022, Circulation.

[6]  Yongfang Zhao,et al.  Corrigendum: Loss of hepatic Surf4 depletes lipid droplets in the adrenal cortex but does not impair adrenal hormone production , 2021, Frontiers in Cardiovascular Medicine.

[7]  Hanying Dai,et al.  Metallothionein 1: A New Spotlight on Inflammatory Diseases , 2021, Frontiers in Immunology.

[8]  Yongfang Zhao,et al.  Atherosclerosis-associated hepatic secretion of VLDL but not PCSK9 is dependent on cargo receptor protein Surf4 , 2021, Journal of lipid research.

[9]  Dan Li,et al.  Mechanisms of Atherosclerosis Induced by Postprandial Lipemia , 2021, Frontiers in Cardiovascular Medicine.

[10]  X. Ruan,et al.  CD36 Senses Dietary Lipids and Regulates Lipids Homeostasis in the Intestine , 2021, Frontiers in Physiology.

[11]  A. Albillos,et al.  The Role of the Gut-Liver Axis in Metabolic Dysfunction-Associated Fatty Liver Disease , 2021, Frontiers in Immunology.

[12]  P. Vizán,et al.  Functional and Pathological Roles of AHCY , 2021, Frontiers in Cell and Developmental Biology.

[13]  N. Kneteman,et al.  Membrane type 1 matrix metalloproteinase promotes LDL receptor shedding and accelerates the development of atherosclerosis , 2021, Nature Communications.

[14]  H. Ginsberg.  ApoB SURFs a Ride from the ER to the Golgi. , 2021, Cell metabolism.

[15]  Jie Luo,et al.  Feeding induces cholesterol biosynthesis via the mTORC1–USP20–HMGCR axis , 2020, Nature.

[16]  Xiangfeng Lu,et al.  Receptor-Mediated ER Export of Lipoproteins Controls Lipid Homeostasis in Mice and Humans. , 2020, Cell metabolism.

[17]  Brian T. Emmer,et al.  The Endoplasmic Reticulum Cargo Receptor SURF4 Facilitates Efficient Erythropoietin Secretion , 2020, Molecular and Cellular Biology.

[18]  D. Ron,et al.  Cargo receptor-assisted endoplasmic reticulum export of pathogenic α1-antitrypsin polymers , 2020, bioRxiv.

[19]  M. Rutlin,et al.  The Villin1 Gene Promoter Drives Cre Recombinase Expression in Extraintestinal Tissues , 2020, Cellular and molecular gastroenterology and hepatology.

[20]  M. A. Alonso,et al.  The formin INF2 in disease: progress from 10 years of research , 2020, Cellular and Molecular Life Sciences.

[21]  P. Tso,et al.  Regulation of intestinal lipid metabolism: current concepts and relevance to disease , 2020, Nature Reviews Gastroenterology & Hepatology.

[22]  Yongfang Zhao,et al.  Surf4 regulates expression of proprotein convertase subtilisin/kexin type 9 (PCSK9) but is not required for PCSK9 secretion in cultured human hepatocytes. , 2020, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[23]  J. Holst,et al.  Postprandial dyslipidemia, hyperinsulinemia, and impaired gut peptides/bile acids in adolescents with obesity. , 2019, The Journal of clinical endocrinology and metabolism.

[24]  Xiaoxu Yang,et al.  The roles of estrogen and estrogen receptors in gastrointestinal disease. , 2019, Oncology letters.

[25]  F. Chaudhry,et al.  Multifaceted regulation of the system A transporter Slc38a2 suggests nanoscale regulation of amino acid metabolism and cellular signaling , 2019, Neuropharmacology.

[26]  K. Adeli,et al.  Intestinal lipogenesis: how carbs turn on triglyceride production in the gut. , 2019, Current opinion in clinical nutrition and metabolic care.

[27]  J. Wallace.  Nitric oxide in the gastrointestinal tract: opportunities for drug development , 2018, British journal of pharmacology.

[28]  G. Lewis,et al.  Regulation of Chylomicron Secretion: Focus on Post-Assembly Mechanisms , 2018, Cellular and molecular gastroenterology and hepatology.

[29]  Ying Yin,et al.  Surf4 (Erv29p) binds amino-terminal tripeptide motifs of soluble cargo proteins with different affinities, enabling prioritization of their exit from the endoplasmic reticulum , 2018, PLoS biology.

[30]  R. Eckel,et al.  Sex differences in lipid and lipoprotein metabolism , 2018, Molecular metabolism.

[31]  J. Vaupel,et al.  Women live longer than men even during severe famines and epidemics , 2018, Proceedings of the National Academy of Sciences.

[32]  K. Adeli,et al.  Postprandial Dyslipidemia: Pathophysiology and Cardiovascular Disease Risk Assessment , 2017, EJIFCC.

[33]  C. Mansbach,et al.  Control of chylomicron export from the intestine. , 2016, American journal of physiology. Gastrointestinal and liver physiology.

[34]  John G. Jones.  Hepatic glucose and lipid metabolism , 2016, Diabetologia.

[35]  M. Hussain,et al.  Circadian regulators of intestinal lipid absorption , 2015, Journal of Lipid Research.

[36]  B. Kahn,et al.  Lipid Extraction from Mouse Feces. , 2015, Bio-protocol.

[37]  M. Boutjdir,et al.  Intestine-specific MTP and global ACAT2 deficiency lowers acute cholesterol absorption with chylomicrons and HDLs , 2014, Journal of Lipid Research.

[38]  M. Hussain,et al.  Intestinal lipid absorption and lipoprotein formation , 2014, Current opinion in lipidology.

[39]  Faqi Wang,et al.  Caveolin-1 interacts with ATP binding cassette transporter G1 (ABCG1) and regulates ABCG1-mediated cholesterol efflux. , 2014, Biochimica et biophysica acta.

[40]  Da-wei Zhang,et al.  Characterization of the role of EGF-A of low density lipoprotein receptor in PCSK9 binding , 2013, Journal of Lipid Research.

[41]  L. Berthiaume,et al.  Characterization of palmitoylation of ATP binding cassette transporter G1: effect on protein trafficking and function. , 2013, Biochimica et biophysica acta.

[42]  I. D'Agnano,et al.  Good Caco-2 cell culture practices. , 2012, Toxicology in vitro : an international journal published in association with BIBRA.

[43]  S. Siddiqi,et al.  Intracellular Trafficking and Secretion of VLDL , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[44]  A. Nusrat,et al.  Gastrointestinal , Hepatobiliary , and Pancreatic Pathology Probiotic Bacteria Induce Maturation of Intestinal Claudin 3 Expression and Barrier Function , 2012 .

[45]  C. Mansbach,et al.  Phosphorylation of Sar1b Protein Releases Liver Fatty Acid-binding Protein from Multiprotein Complex in Intestinal Cytosol Enabling It to Bind to Endoplasmic Reticulum (ER) and Bud the Pre-chylomicron Transport Vesicle* , 2012, The Journal of Biological Chemistry.

[46]  N. Davidson,et al.  A novel multiprotein complex is required to generate the prechylomicron transport vesicle from intestinal ER[S] , 2010, Journal of Lipid Research.

[47]  K. Adeli,et al.  Proteomic profiling of intestinal prechylomicron transport vesicle (PCTV)-associated proteins in an animal model of insulin resistance (94 char). , 2010, Journal of proteomics.

[48]  J. Goldstein,et al.  The LDL receptor. , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[49]  A. Lichtenstein,et al.  Gender-Specific Differences in the Kinetics of Nonfasting TRL, IDL, and LDL Apolipoprotein B-100 in Men and Premenopausal Women , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[50]  Annik Prat,et al.  Proprotein convertase subtilisin/kexin type 9 (PCSK9): Hepatocyte‐specific low‐density lipoprotein receptor degradation and critical role in mouse liver regeneration , 2008, Hepatology.

[51]  Maristela L Onozato,et al.  Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. , 2007, American journal of physiology. Heart and circulatory physiology.

[52]  T. Gheyi,et al.  Liver Fatty Acid-binding Protein Initiates Budding of Pre-chylomicron Transport Vesicles from Intestinal Endoplasmic Reticulum* , 2007, Journal of Biological Chemistry.

[53]  E. Sato,et al.  Effect of starvation on the survival of male and female mice. , 2007, Physiological chemistry and physics and medical NMR.

[54]  H. Kondo,et al.  Differential regulation of intestinal lipid metabolism-related genes in obesity-resistant A/J vs. obesity-prone C57BL/6J mice. , 2006, American journal of physiology. Endocrinology and metabolism.

[55]  P. Tso,et al.  CD36 is important for chylomicron formation and secretion and may mediate cholesterol uptake in the proximal intestine. , 2006, Gastroenterology.

[56]  F. Gorelick,et al.  The Identification of a Novel Endoplasmic Reticulum to Golgi SNARE Complex Used by the Prechylomicron Transport Vesicle* , 2006, Journal of Biological Chemistry.

[57]  F. Gorelick,et al.  Vesicle-associated membrane protein 7 is expressed in intestinal ER , 2006, Journal of Cell Science.

[58]  S. Young,et al.  Compensatory Increase in Hepatic Lipogenesis in Mice with Conditional Intestine-specific Mttp Deficiency* , 2006, Journal of Biological Chemistry.

[59]  D. Rader,et al.  Determining hepatic triglyceride production in mice: comparison of poloxamer 407 with Triton WR-1339 Published, JLR Papers in Press, July 1, 2005. DOI 10.1194/jlr.D500019-JLR200 , 2005, Journal of Lipid Research.

[60]  K. Adeli,et al.  Intestinal assembly and secretion of highly dense/lipid-poor apolipoprotein B48-containing lipoprotein particles in the fasting state: evidence for induction by insulin resistance and exogenous fatty acids. , 2005, Metabolism: clinical and experimental.

[61]  N. Davidson,et al.  Intestinal lipoprotein assembly in apobec-1-/- mice reveals subtle alterations in triglyceride secretion coupled with a shift to larger lipoproteins. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[62]  Jay D. Horton,et al.  Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[63]  F. Gorelick,et al.  COPII proteins are required for Golgi fusion but not for endoplasmic reticulum budding of the pre-chylomicron transport vesicle , 2003, Journal of Cell Science.

[64]  D. Gerhard,et al.  Novel mutations of APOB cause ApoB truncations undetectable in plasma and familial hypobetalipoproteinemia , 2002, Human mutation.

[65]  J. Storch,et al.  The fatty acid transport function of fatty acid-binding proteins. , 2000, Biochimica et biophysica acta.

[66]  G. Shearer,et al.  Estrogen effects on triglyceride metabolism in analbuminemic rats. , 2000, Kidney international.

[67]  J. Björkegren,et al.  Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. , 1999, The Journal of clinical investigation.

[68]  S. Young,et al.  Chylomicron-sized lipid particles are formed in the setting of apolipoprotein B deficiency. , 1998, Journal of lipid research.

[69]  J. Borén,et al.  Inhibition of the Microsomal Triglyceride Transfer Protein Blocks the First Step of Apolipoprotein B Lipoprotein Assembly but Not the Addition of Bulk Core Lipids in the Second Step* , 1996, The Journal of Biological Chemistry.

[70]  Robert V Farese,et al.  A genetic model for absent chylomicron formation: mice producing apolipoprotein B in the liver, but not in the intestine. , 1995, The Journal of clinical investigation.

[71]  D. Rader,et al.  Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. , 1992, Science.

[72]  Kermit T. Hoyenga,et al.  Gender and energy balance: Sex differences in adaptations for feast and famine , 1982, Physiology & Behavior.

[73]  H. Scott,et al.  Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. , 1970, Archives of surgery.

[74]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.